Peripheral T-cell lymphoma (PTCL) is a rare and diverse group of aggressive non-Hodgkin lymphomas that originate from mature T-cells and natural killer (NK) cells, often presenting with a poor prognosis due to its resistance to standard chemotherapy regimens. Its diagnosis and treatment require a nuanced approach, incorporating advanced molecular diagnostics and targeted therapies to improve outcomes.